Fresenius SE & Co KGaA logo

FRE - Fresenius SE & Co KGaA Share Price

€39.44 -0.7  -1.7%

Last Trade - 18/09/20

Sector
Healthcare
Size
Large Cap
Market Cap £19.95bn
Enterprise Value £51.28bn
Revenue £33.19bn
Position in Universe 53rd / 1040
Bullish
Bearish
Unlock FRE Revenue
Momentum
Relative Strength (%)
1m -0.53%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -23.5%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
23,459 27,995 29,471 33,886 33,530 35,409 36,866 38,818 +8.6%
+2.6 +30.5 +13.8 +20.1 -25.4 +34.0 -7.80 +12.5
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the six months ended 30 June 2020, Fresenius SE & Co KGaA revenues increased 5% to EUR18.06B. Net income decreased 6% to EUR870M. Revenues reflect Fresenius Medical Care segment increase of 7% to EUR9.02B, Fresenius Helios segment increase of 3% to EUR4.77B, North America segment increase of 7% to EUR7.67B, Europe segment increase of 3% to EUR7.74B. Net income was offset by Selling/General/Admin Expense increase of 3% to EUR2.63B (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for FRE
Graphical History

Revenue

FRE Revenue Unlock FRE Revenue

Net Income

FRE Net Income Unlock FRE Revenue

Normalised EPS

FRE Normalised EPS Unlock FRE Revenue

PE Ratio Range

FRE PE Ratio Range Unlock FRE Revenue

Dividend Yield Range

FRE Dividend Yield Range Unlock FRE Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
FRE EPS Forecasts Unlock FRE Revenue
Profile Summary

Fresenius SE & Co KGaA is a Germany-based healthcare group. It operates through four business segments. Fresenius Medical Care runs a global network of dialysis clinics, providing treatment for patients with chronic kidney failure. It also offers dialyzers, dialysis machines and renal pharmaceuticals. Fresenius Kabi specializes in intravenously administered generic drugs (IV drugs), clinical nutrition and infusion therapies. It also supplies hospitals with medical devices and products of transfusion technology. Fresenius Helios is a private hospital operator, with over 130 facilities in Germany, including maximum care hospitals and rehabilitation centers and, through Quironsalud, over 80 hospitals and outpatient centers, as well as approximately 300 Occupational Risk Prevention Centers in Spain. Fresenius Vamed manages projects and provides services for health care facilities worldwide, from development and turnkey construction to maintenance and total operational management.

Directors
Last Annual December 31st, 2019
Last Interim June 30th, 2020
Incorporated January 28, 2011
Public Since December 18, 1986
No. of Shareholders: n/a
No. of Employees: 302,846
FRE Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for FRE
Upcoming Events for FRE
Monday 21st September, 2020
Fresenius SE & Co KGaA at Baader Investment Conference (Virtual)
Tuesday 22nd September, 2020
Fresenius SE & Co KGaA at Berenberg and Goldman Sachs German Corporate Conference (Virtual)
Thursday 29th October, 2020
Q3 2020 Fresenius SE & Co KGaA Earnings Release
Thursday 29th October, 2020
Q3 2020 Fresenius SE & Co KGaA Earnings Call
Thursday 18th February, 2021 Estimate
Full Year 2020 Fresenius SE & Co KGaA Earnings Release
Frequently Asked Questions for Fresenius SE & Co KGaA
What is the Fresenius SE & Co KGaA share price?

As of 18/09/20, shares in Fresenius SE & Co KGaA are trading at €39.44, giving the company a market capitalisation of £19.95bn. This share price information is delayed by 15 minutes.

How has the Fresenius SE & Co KGaA share price performed this year?

Shares in Fresenius SE & Co KGaA are currently trading at €39.44 and the price has moved by -12.96% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Fresenius SE & Co KGaA price has moved by -6.56% over the past year.

What are the analyst and broker recommendations for Fresenius SE & Co KGaA?

Of the analysts with advisory recommendations for Fresenius SE & Co KGaA, there are there are currently 9 "buy" , 4 "hold" and 1 "sell" recommendations. The overall consensus recommendation for Fresenius SE & Co KGaA is Buy. You can view the full broker recommendation list by unlocking its StockReport.

When will Fresenius SE & Co KGaA next release its financial results?

Fresenius SE & Co KGaA is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-06-30
What is the Fresenius SE & Co KGaA dividend yield?

The Fresenius SE & Co KGaA dividend yield is 2.13% based on the trailing twelve month period.

Does Fresenius SE & Co KGaA pay a dividend?

Last year, Fresenius SE & Co KGaA paid a total dividend of 0.84, and it currently has a trailing dividend yield of 2.13%. Looking ahead, Fresenius SE & Co KGaA has not announced an ex-dividend date yet.

When does Fresenius SE & Co KGaA next pay dividends?

Fresenius SE & Co KGaA has yet to annouce their ex-dividend date. The historic dividend yield on Fresenius SE & Co KGaA shares is currently 2.13%.

How do I buy Fresenius SE & Co KGaA shares?

To buy shares in Fresenius SE & Co KGaA you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Fresenius SE & Co KGaA?

Shares in Fresenius SE & Co KGaA are currently trading at €39.44, giving the company a market capitalisation of £19.95bn.

Where are Fresenius SE & Co KGaA shares listed? Where are Fresenius SE & Co KGaA shares listed?

Here are the trading details for Fresenius SE & Co KGaA:

Country of listing: Germany
Exchange: GER
Ticker Symbol: FRE
What kind of share is Fresenius SE & Co KGaA?

Based on an overall assessment of its quality, value and momentum, Fresenius SE & Co KGaA is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Fresenius SE & Co KGaA share price forecast 2020?

Shares in Fresenius SE & Co KGaA are currently priced at €39.44. At that level they are trading at 33.87% discount to the analyst consensus target price of 0.00.

Analysts covering Fresenius SE & Co KGaA currently have a consensus Earnings Per Share (EPS) forecast of 3.276 for the next financial year.

How can I tell whether the Fresenius SE & Co KGaA share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Fresenius SE & Co KGaA. Over the past six months, the relative strength of its shares against the market has been 6.44%. At the current price of €39.44, shares in Fresenius SE & Co KGaA are trading at -7.51% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Fresenius SE & Co KGaA PE Ratio?

The Fresenius SE & Co KGaA PE ratio based on its reported earnings over the past 12 months is 11.68. The shares are currently trading at €39.44.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Fresenius SE & Co KGaA?

Fresenius SE & Co KGaA's management team is headed by:

Gerd Krick - CSU
Stephan Sturm - CMG
Juergen Goetz - CCO
Konrad Koelbl - IND
Niko Stumpfoegger - VSU
Francesco De Meo - MGB
Ernst Wastler - MGB
D. Michael Albrecht - IND
Mats Henriksson - MGB
Rice Powell - MGB
Michael Diekmann - VSU
Stefanie Balling - IND
Oscar de Paco - IND
Rachel Empey - CFO
Bernd Behlert - IND
Who are the major shareholders of Fresenius SE & Co KGaA?

Here are the top five shareholders of Fresenius SE & Co KGaA based on the size of their shareholding:

Else Kroner-Fresenius Foundation Corporation
Percentage owned: 27% (150.5m shares)
Allianz Global Investors GmbH Investment Advisor
Percentage owned: 4.98% (27.7m shares)
BlackRock Institutional Trust Company, N.A. Investment Advisor
Percentage owned: 4.89% (27.3m shares)
DWS Investment GmbH Investment Advisor/Hedge Fund
Percentage owned: 2.98% (16.6m shares)
Capital Research Global Investors Investment Advisor
Percentage owned: 2.47% (13.8m shares)
Similar to FRE
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.